112 related articles for article (PubMed ID: 16886576)
1. [Experimental methods in the treatment of Leśniowski-Crohn disease].
Gutkowski K; Bilkiewicz T
Pol Merkur Lekarski; 2006 Apr; 20(118):457-61. PubMed ID: 16886576
[TBL] [Abstract][Full Text] [Related]
2. [The conservative treatment of nonspecific inflammatory bowel diseases].
Wojtuń S; Gil J; Chojnacki J; Wichan P
Pol Merkur Lekarski; 2004; 17 Suppl 1():35-9. PubMed ID: 15603344
[TBL] [Abstract][Full Text] [Related]
3. Budesonide for Crohn's disease.
Seow CH; Benchimol EI; Steinhart AH; Griffiths AM; Otley AR
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):971-9. PubMed ID: 19611401
[TBL] [Abstract][Full Text] [Related]
4. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
Vermeire S; van Assche G; Rutgeerts P
Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
[TBL] [Abstract][Full Text] [Related]
5. Cytokines and mucosal inflammatory response in Crohn's disease.
van Deventer SJ
Eur J Surg; 1998 Dec; 164(12):897-901. PubMed ID: 10029384
[No Abstract] [Full Text] [Related]
6. Review article: Medical therapy for fistulizing Crohn's disease.
Bressler B; Sands BE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
[TBL] [Abstract][Full Text] [Related]
7. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha antagonists: benefits beyond remission.
Mahadevan U
Rev Gastroenterol Disord; 2007; 7 Suppl 1():S13-9. PubMed ID: 17392633
[TBL] [Abstract][Full Text] [Related]
9. Novel strategies to attenuate immune activation in Crohn's disease.
Bamias G; Cominelli F
Curr Opin Pharmacol; 2006 Aug; 6(4):401-7. PubMed ID: 16753341
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of Lesniowski-Crohn disease of the upper part of the gastrointestinal tract].
Gadowska-Cicha A; Latos W; Niepsuj KJ; Sieroń A
Wiad Lek; 2005; 58(5-6):307-12. PubMed ID: 16238123
[TBL] [Abstract][Full Text] [Related]
11. Visceral fat and gut inflammation.
Drouet M; Dubuquoy L; Desreumaux P; Bertin B
Nutrition; 2012 Feb; 28(2):113-7. PubMed ID: 22208553
[TBL] [Abstract][Full Text] [Related]
12. Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.
Danese S; Angelucci E; Stefanelli T; Omodei P; Luigiano C; Finazzi S; Pagano N; Repici A; Vecchi M; Malesci A
Digestion; 2008; 77(2):96-107. PubMed ID: 18382085
[TBL] [Abstract][Full Text] [Related]
13. Management of inflammatory bowel disease in adults.
Katz JA
J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
[TBL] [Abstract][Full Text] [Related]
14. How to modulate inflammatory cytokines in liver diseases.
Tilg H; Kaser A; Moschen AR
Liver Int; 2006 Nov; 26(9):1029-39. PubMed ID: 17032402
[TBL] [Abstract][Full Text] [Related]
15. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
Sandborn WJ; Feagan BG; Lichtenstein GR
Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of medically induced remission of Crohn's disease.
Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
20. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease.
Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P
Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
